Staying Real in Israel
Home of
"The Marty Roberts Show"

Chalk up Nobel Prize number 10 for Israel…

Listen to the show…

Podcast: Play in new window | Download

Ten Nobel laureates in 45 years for Israel…a country with only 7.8 million people…A country with more engineers per capita than any other nation in the world…A country second only to the US in the number of NASDAQ-listed companies…

Israel…”Whadda country!!…”

Also on todays show:

Speaking of Israeli brainpower…a profile of Mooly Eden, president of Intel Israel. He was recently named by Fortune magazine as one of the world’s 10 most brilliant technological minds…

Also…The technological and academic achievements start with Israel’s young students…

Israeli high school team “The Pink Eagles” takes first place in an international robotics competition…

Southern Israel’s yeshiva high school team collects the silver for second place in another international contest…this time, it’s the FLL Global Innovation competition…

Continue reading “Israel May Be Tiny in Size, But When It Comes To Brainpower and Scientific Achievement…She is A Real Giant” »

In the United States, Too?…

Listen to the show…

Podcast: Play in new window | Download

It’s getting a bit scary when a Jew is not allowed to place a mezuzah on her condominium doorpost…

A new report shows an alarming rise on restrictions on religion around the world, and we’re not just talking 3rd world, primitive countries…

Also On Today’s Show:

The Israeli fashion industry…A new, ground-breaking Israeli law aimed at protecting fashion models is passed…it bans under-weight fashion models and requires disclosure of altered photos of them…

Plus…Naomi Campbell visits Israel…but no Jewish reporters allowed to cover her in Bethlehem…Israel gets a fashion channel…And…Israeli celebs are part of the Gc Swiss watch photo campaign…

The world’s largest mezuzah is hung on Israel’s Kaplan hospital…

Also…Mothering in Israel vs. the rest of the world…Israel’s most prestigious and popular professions…

(Hint: You should be good Jewish doctor, nu?)

And…Number two on the list are scientific positions…thereby explaining all the world-changing “stuff” coming out of Israel…like Ben-Landas nanographic printing method…

And the new, Israeli-made insulin pump…

Not to mention, the discovery in Israel of a “longevity gene”…the evasive fountain of youth???

All this and more on The Marty Roberts Show

Listen to the show…

Podcast: Play in new window | Download

Israel is ranked the second most educated country in the world…and we are all benefiting from her wisdom

Radio Show/Podcast!!!

Listen to the show…

Podcast: Play in new window | Download

More than 45% of Israel’s population has completed post secondary education

Stories of Israeli doctors saving lives around the world and training third-world health care professionals, not to mention saving the lives of her enemies’ children…

Israeli drug companies are taking down killer diseases one by one…Cancer, diabetes…no disease shall remain un-cured or non-vaccinated against…

Listen to the stories…

Plus…Oliver Stone’s son converts to Islam…in Iran!!

All this and more on The Marty Roberts Show

Listen to the show…

Podcast: Play in new window | Download

You might miss out on the world’s first vaccine and cure for cancer!!!

Breast cancer cells

If you want to boycott Israel, do so at your own risk…the risk of being left behind, swept back to the dark ages…stripped of most of the benefits of modern science, technology and medical research…much of which comes out of the tiny little country called ISRAEL…

Boycott Israel…No, I don’t think so…not if you have even half a brain…

Eureka: World’s First Vaccine and Cure For Cancer Developed by Israeli Medicine Company

The BIG NEWS of a Cancer Curing Drug is coming in from Israel.

Reprinted from techie-buzz.com

An Israeli company has come up with a vaccine against cancer that is both safe in terms of no side-effects and can be administered as a drug. Vaxil BioTherapeutics has developed a vaccine that is now undergoing clinical trials and not yet available in the market. It is being tested at Hadassah University Medical Center in Jerusalem and the trials could take as long as six years to conclude.

A vaccine that is also a drug

The vaccine also acts like a drug, i.e. it can be administered to a sick person as a cure. The vaccine is being tested against a form of blood cancer called multiple myeloma and it is generating enough success. Vaxil says that it could be used against other types of cancer as well, including the common prostrate and breast cancer. The primary immune technology, called VaxHit, can then be developed for other forms of cancer.

How the drug works

The problem with cancer is that the immune system of the body doesn’t know what exactly it should do. The Vaxil product, called ImMucin, “trains” the immune system to act in a specific way. Cancer cells have a marker called MUC1 that is unique to cancer cells only. ImMucin trains “T-cells” of our immune system to attack only those cells that are marked by the MUC1 marker. The success rate of the vaccine has not been revealed, but it is supposedly phenomenal. The diversification of the vaccine stems from the fact that MUC1 marks more than 90% of the different cancer cells. Furthermore, since only those cells marked with MUC1 are targeted, the drug has no side-effects and is completely safe to use.

This may be the ultimate magic bullet that scientists have been working towards for a long time. However, there are still a few clinical tests to go.
Vaxil’s Homepage: http://www.vaxilbio.com/

In some tests, like war, for instance, you only get one chance to do or die, but, given a second chance, it pays to learn from your mistakes…

Radio Show/Podcast!!!

Listen to the show…

Podcast: Play in new window | Download

And that is exactly what Israel has done in dealing with repeated attempts to illegally break the Naval blockade set up to prevent arms smuggling into Gaza, flotilla or airlift…

Israels successful thwarting of “Summer Flotilla II” and the attempted “Human Airlift” of protestors to Ben Gurion Airport…

As Borat would put it, “Great Success!!”…

Also…I-Pod apps…The good, the bad and the discontinued, including some hot Israeli ideas and some not-so-hot palestinian ones…

And…Paul Simon, The Yardbirds and Ziggy Marley…in Israel soon…

Plus…Israel’s first Air Force pilot wearing a long skirt…Religiously observant AND female!…

All this and more on “The Marty Roberts Show”…

Listen to the show…

Podcast: Play in new window | Download

More evidence of the importance of the Jewish State to the world, not just to the Jews…

The Israeli economy continues to be strong, offsetting the economic collapse taking place in the rest of the world.

Israel ranked 14th in global innovation

Jewish state gains nine spots over last year’s position in GII, which recognizes key role of innovation as driver of economic growth and prosperity

Reprinted from ynetnews.com

The results for the fourth edition of The Global Innovation Index (GII) 2011 have just been published and Israel is ranked number 14, a significant improvement over its number 23 position last year.

The GII recognizes the key role of innovation as a driver of economic growth and prosperity.

Launched in 2007 by INSEAD eLab, the GII has become an important tool in benchmarking continued progress in countries. The GII provides advanced metrics and approaches to better capture the richness of innovation in society and go beyond traditional measurers.

With a population of 7.3 million, Israel is ranked number 96 in global population.

The top three ranked countries in the Index are Switzerland, Sweden and Singapore. The United States is ranked seventh with Canada below them at eight.

The only other Middle Eastern country in the top 30 is Qatar at 26.

Never have to buy gas again…Ever!!!…

Radio Show/Podcast!!!

Listen to the show…

Podcast: Play in new window | Download

The story of Shai Agassi and his revolutionary “Better Place” start-up…How it happened, how the system works, why it’s better than hybrids…
The first step towards eliminating the world’s need for arab oil?…

Better Place Founder Shai Agassi

Also…The Dutch parliament takes the first step towards banning kosher meat in The Netherlands…What does this mean to the Jews?…Is there possibly a higher message being sent here?…

Ban Shakira Facebook Page

Plus…Shakira…Banned in Egypt?…Why?…Because she visited Israel!…Welcome to the new Spring-time arab democracy in Egypt…

All this and more on “The Marty Roberts Show”…

Listen to the show…

Podcast: Play in new window | Download

From the Israeli scientist that brought you crossword puzzles for the blind…bigger and better things for the visually challenged…

Israeli scientists develop ‘virtual cane’

Hebrew University unveils innovation which could significantly improve orientation, mobility of sight-impaired people

Reprinted from ynetnews.com

Yissum Research Development Company Ltd, the technology transfer company of the Hebrew University of Jerusalem presented a major new innovation – a virtual cane that will significantly improve the orientation and mobility of sight-impaired people.

The new device can assist blind people in estimating the distance and height of various obstacles. The invention was patented by Yissum, which is now seeking strategic partners for further development.

Dr. Amir Amedi from the Institute for Medical Research Israel-Canada (IMRIC) and at Edmond and Lily Safra Center for Brain Sciences (ELSC) at The Hebrew University of Jerusalem and his team recently developed the device to help in spatial navigation for the blind.

Unlike a white stick that can give the blind input from only a meter away, the device can function at a much shorter distance and up to some 10 meters in all directions. Dr. Amedi said the device can also distinguish between smiling and sad faces and can be used for research on how the brain flexibly changes upon receiving input and on brain reorganization in the blind.

Amedi added that the blind user functions like a dolphin or bat, with sonar-type signals reacting to surroundings.

The invention, which was unveiled at the Presidential Conference last week, functions as a virtual flashlight and can replace or augment the classic white cane. The virtual cane emits a focused beam towards surrounding objects, and transmits the information to the user via a gentle vibration, similar to a cell phone vibration.

A Yissum press release noted that the cane incorporates several sensors that estimate the distance between the user and the object it is pointed at. This allows the blind person to assess the height and distance of various objects, reconstruct an accurate image of the surroundings and navigate safely.

The virtual cane is extremely small, easy to carry, accurate, can function for up to 12 hours and is easy to charge. Using the device is highly intuitive and can be learnt within a few minutes.

Yaacov Michlin, CEO of Yissum said, “Dr. Amedi’s promising invention can endow visually impaired people with the freedom to freely navigate in their surroundings without unintentionally bumping into or touching other people and thus has the potential to significantly enhance their quality of life.”

Yissum is a Research Development Company of the Hebrew University and was founded in 1964 to protect and commercialize the Hebrew University’s intellectual property.

Israel’s economy is growing, jobs are being created, innovation and entrepeneurs flourish in the Jewish State…
If you are Jewish, you might want to consider coming home…the benefits are wide and varied…

High-tech work force rises 2% in 2010

The Central Bureau of Statistics also reported that business output in the sector rose 5.3% last year.

Reprinted from globes.co.il

The increase in GDP (gross domestic product) in the business sector in 2010 did not reflect the rate of growth in the information technology field (IT). Israel’s Central Bureau of Statistics reported that the GDP in the IT field totaled NIS 73 billion in 2010, up 2% from 2009. This is compared with a rise of 5.3% in the market’s business output sector.

The Central Bureau of Statistics reported that the disappointing increase in 2010 does not accurately reflect the situation. According to statistics from the last decade, the annual increase in the IT sector is estimated at 5%, as compared with an increase in 4% from the business output sector. Export industries totaled $18.8 billion, 27% of all export products and services.

Exports in the IT field decreased significantly compared with 2009, when the proportion of exports was 31%. But apparently it is 2009 that was the exception, since the average export rate in IT from 1997-2010 was 24% of all exports, which means that 2010′s rate of 27% was not bad at all in comparison.

Improved situation

The data reflect economic behavior in the relevant sectors according to the definitions in OECD countries for the IT sector. According to the data, the number of people employed in this sector began growing in 2010, and provided jobs for an additional 7,000 people, an increase of 3%, as compared with a decrease of 2,000 jobs in 2009. In total, about 218,000 people are employed in the IT sector (or 174,000 excluding communication services), about 6.8% of all employees in the market (5.4% excluding communication services).

According to the data, the bulk of the increase in new employees was felt in service related fields such as computing services and start-up companies, which mainly provide pre-sales R&D. The number of employees in this category increased 3,700. This improvement is also reflected regarding salaries, which grew about 2.5% in 2010, and amounted to an average of NIS 243,000 a year. The sectors that stand out are R&D services, communications hardware, and industrial and medical equipment.

Their product is windows that protect a building’s occupants from radiation, while generating power at the same time…
Brilliant!…Israeli ingenuity…

Pythagoras Solar Window

GE awards Israeli startup $100,000 ‘Ecomagination’ grant

Pythagoras Solar creates windows that protect against solar radiation and produce useable energy, CEO says.

Reprinted from jpost.com

GE awards Israeli startup $100,000 ‘Ecomagination’ grant
By SHARON UDASIN
06/27/2011 04:33

Pythagoras Solar creates windows that protect against solar radiation and produce useable energy, CEO says.
Talkbacks (1)

An Israeli solar company that employs windows to both block solar radiation and harness energy from the sun has received a $100,000 grant from General Electric and partners’ “Ecomagination” program, the corporation announced this weekend.

The company, called Pythagoras Solar, is one of five firms to win an Innovation Award from the program’s “Powering Your Home” challenge, in which GE invested $63 million this round and also provided sizeable awards to 10 commercial partners in addition to the smaller firms. Currently in its second year, the challenge has now provided a total of $200 million worth of funds to 22 commercial corporations and 10 startups in total, with an aim of “accelerating the global development of clean energy technologies,” the corporation said. A panel of independent judges selected the winners and included Wired Magazine editor Chris Anderson, executives from GE and academics leaders from the field, according to a statement from the company.

“We knew that GE recognized that this technology could have a huge impact on the way buildings are being built,” co-founder and CEO of Pythagoras Solar, Golan Fink, told The Jerusalem Post on Sunday.

“This is the part of the award that we are most happy about and feel good about the validation and feedback we have.” Pythagoras, established by Golan Fink and partner Dr.

Itay Baruchi in 2007, employs a technology called “Building Integrated Photovoltaics,” which aims to achieve “netzero buildings” in terms of energy consumption.

“The windows themselves include a combination of optical devices and solar cells,” Fink explained. “The unique thing about this combination is that the optical device manipulates sunlight so that instead of getting into the room, the direct radiation is used for generating clean solar energy. It produces energy and also shades the room.” While the company currently has five pilots running – three in the United States and two in Israel – the most longrunning trial has been going on now for six months at the Sears Tower in Chicago, Illinois, according to Fink.

“The Sears Tower itself is looking at the project as part of retrofitting the building,” he said. “Even though Chicago is not the best place for concentrated solar energy, it still suffers from getting too much heat.

“We are looking for this to be the greenest building in the US,” he continued.

They wanted to evaluate this technology because of its unique combination of solar power generation and energy efficiency.” Pythagoras is also in the process of evaluating several potential projects in China, Fink added.

“There is a lot of construction happening in China, and they are not on the forefront of energy efficiency,” he said.

“There are some projects there that are moving more and more toward the green construction industry.” While the company is currently in the process of developing a type of window that would be more appropriate for residential locations, Fink said that the current models – which will hit commercial markets in the US by the end of this year – are better suited for larger buildings at the moment.

“It’s more relevant for buildings with significant amount of glass,” he said, noting, however, that the building need not be as tall as the Sears Tower.

“The current product is less applicable for residential windows because you need a large surface of glass to make this economical.” Fink added that the company hopes to move to marketing larger volumes of installations by next year.

In addition to Pythagoras Solar, the other four startup winners this year were British firm E.quinox for its renewable energy in developing countries, as well as American companies PlotWatt for its smart meter analysis, Suntulit for its climate control systems and Xergy for its green refrigeration systems, according to GE.

GE’s decision to include the Israeli firm among its winners comes just shortly after the corporation opened a multidisciplinary research and development center in Israel, where it will host local projects in medical technologies, clean energy and water – with the hopes of advancing technology by partnering with Israeli companies and academics, the corporation said.

An Israeli-developed cell-based product for treating the scourge of pulmonary hypertension will be hitting the market…

…and adding to the already VERY long list of lives saved by Israel…

Pluristem soars on agreement with United Therapeutics

United Therapeutics will use Pluristem’s PLacental eXpanded cells to develop and commercialize a treatment for pulmonary hypertension

Reprinted from globes.co.il

Pluristem Therapeutics Ltd. (Nasdaq:PSTI; DAX: PJT: PLTR) has signed an exclusive out-license agreement with United Therapeutics Corporation (Nasdaq: UTHR) for the use of Pluristem’s PLacental eXpanded (PLX) cells to develop and commercialize a cell-based product for the treatment of pulmonary hypertension (PH). United Therapeutics will receive exclusive worldwide licensing rights for the development and commercialization of the future product for treating PH patients. Pluristem will retain its intellectual property – the PLX cells – and all manufacturing rights. It will participate in the pre-clinical and clinical trial activities and provide the commercial grade product.

United Therapeutics will pay Pluristem an initial $7 million and milestone and other payments for a total of $55 million. Pluristem will also be reimbursed for costs of development and clinical activities. United Therapeutics will bear all the costs of conducting the clinical trials for this indication. Following commercialization, United Therapeutics will purchase commercial supplies from Pluristem at a specified margin over Pluristem’s cost, and it will also pay Pluristem specified royalties as a percentage from its gross profits generated from the developed product.

“This is an important milestone for our company, as it exemplifies our belief that Pluristem’s PLX cells are a platform technology that can be used for the treatment of numerous diseases. This agreement is in line with our strategy of being a state of the art cell manufacturer while maintaining all the production and Intellectual Property rights for future product candidates,” said Pluristem chairman and CEO Zami Aberman.

United Therapeutics president and CEO Roger Jeffs said, “Our mission to help patients suffering from pulmonary hypertension has led us to seek companies exhibiting innovative approaches and cutting edge technology, with whom we could partner for developing new therapies. Pluristem’s impressive results of their current clinical trials, their strong intellectual property and unique manufacturing capabilities, convinced us to select Pluristem as our partner in developing an important cell therapy for treating PH. We are excited to enter into this partnership and to work alongside Pluristem in advancing this exciting platform.”

Surrounded by so many enemies and military threats, Israel has no choice but to be good at defending herself…

…and Israel’s military know-how is on display and for sale in Paris…

Israel’s show of force in Paris

A NIS 6 million pavilion will support Israel’s defense exports effort at the Paris Air Show

Reprinted from globes.co.il

For weeks, it has been impossible to ignore the superlatives being heaped by the heads of Israel’s defense companies on the business potential of the Paris Air Show, which will open next week and will attract some 400,000 visitors from all over the world. As they attempt to stand out among the multi-national giants and make an impression, the Israeli companies that will exhibit there will reveal everything that they are allowed to reveal: from new concepts in land warfare and innovative systems for active defense of armored vehicles, to advanced missile systems; spy and communications satellites; sophisticated radars; UAVs that do everything except make the coffee. The list is long, long enough to explain how it is that a country like Israel sells the world defense systems to the tune of $7.2 billion annually, and is up there with the leading countries in the sector, the US, Russia, France, and the UK.

A NIS 6 million pavilion

A defense power like Israel needs suitable accommodation. The Israel Export Institute rose to the occasion, and paid out generously: more than NIS 6 million has been invested in setting up the Israeli pavilion at Le Bourget. It took five weeks to construct, with 40 people working six days a week. The pavilion has an area of 1,000 square meters, and it is made of 60 tons of metal and glass.

Most of the attention this year will be on the Iron Dome rocket interceptor system, and the Trophy system for intercepting anti-tank missiles, both developed by Rafael. Iron Dome, which will shortly be offered for export, will be exhibited bearing the halo of success from its interception of a Grad rocket fired from Gaza just days after it was deployed in the south of Israel. Alongside it will be exhibited a missile interception still under development, Magic Wand (also known as David’s Sling). According Ministry of Defense director general Udi Shani, “Exhibiting the systems, after the impressive success of Iron Dome, represents potential for another growth engine for Israeli defense exports.”

Elbit seizes territory

Public company Elbit Systems Ltd. (Nasdaq: ESLT; TASE: ESLT) also has something new to offer at the show. It intends to unveil an innovative concept for seizing territory, enabling a military force to control an area remotely, using a package of products from the company. A multimedia presentation produced for the show will illustrate the systems’ capabilities through an imaginary scenario in which special forces are sent on a dangerous rescue operation in the heart of an urban area, involving a landing via assault helicopter.

Apart from the impressive presentation, Elbit will unveil for the first time, in full size, its advanced C-Music pod carried in the hold of a civilian aircraft and designed to protect it from shoulder-launched missiles. The system, the first of its kind in the world, is based on a laser that disrupts the missile’s flight. Aircraft of Israeli airlines are due to be equipped with the system.

Elbit will also exhibit its Targo pilot’s helmet, which is mainly used for training, and is accompanies the mission from planning through to debriefing.

IAI goes it alone

Israel Aerospace Industries (IAI) will exhibit its products in its own pavilion, where it will set up a “missile farm” in which it will display the launch battery of its Barak-8 air defense system, together with the missile itself, as well as the ground-to-ground missile interceptors Arrow 2 and Arrow 3, the latter still in development. Alongside them will be its Jumper and Lora artillery missiles.

IAI will also unveil its MLGB laser-guided bomb, which is adaptable to various types of aircraft, and homes onto its target using laser or GPS. IAI says that the weapon’s high accuracy and its lightweight warhead make it suitable for strikes in populated areas, diminishing the risk to civilians and nearby structures.

IMI’s rocket

Israel Military Industries (IMI) will not have its own pavilion, but will open a deals room attended by CEO Avi Felder, and will exhibit some of its systems for export in the Israel pavilion, among them the Refaim urban warfare system, and the Delilah air-to-ground missile, and IMI’s rocket trajectory correction system, which facilitates accurate strikes on targets deep n enemy territory and the destruction of rocket launchers, artillery, and radar installations. These two systems have been in use with the IDF for several years, and proved their effectiveness in the Second Lebanon War, when they made possible accurate hits on Hizbullah targets and on trucks transporting weapons for it in South Lebanon.

Israel Export Institute CEO Avi Hefetz says that 15 Israeli defense companies will exhibit over the six days of the Paris Air Show. “The Israel Export Institute will place its emphasis on the less well known companies, to help them arrange focused business meetings, because the big companies are already known to the market. However, deals do not come to fruition at one exhibition, large as it might be. It takes a long time before a deal is finalized, but an exhibition like this is an excellent opportunity for sowing the seeds of future deals.”

Stinky breath…more politely known as “Halitosis”, or “Bad Breath”

When the “start-up nation” smells a bad smell…we find an innovative way to fix it…

Here, in Israel, we know how to make a pile of poop smell like roses…

A lollipop to banish bad breath

Israeli startup Breezy has developed a patented mint candy to keep breath fresh for up to four hours, with the help of microcapsules that gently clean the tongue

Reprinted from Israel21c

With some 50% of people suffering halitosis, Breezy CEO Hillel Lerman anticipates a lot of interest in his product.

Those old mouthwash commercials had it right: Bad breath, as clichéd as it sounds, really is a big problem. If it weren’t, there wouldn’t be quite so many products on drugstore shelves to combat it. The only problem is that most of them don’t work.

“There are toothpastes, mouthwashes, candies and gums you can buy to treat bad breath, but all they do is mask the problem for a few minutes,” claims Hillel Lerman, the CEO of Israeli startup Breezy. “There is no solution that treats the root of the problem – except ours.”

That solution is Breezy’s Like lollipop, a sugar-free candy confection that removes the bacteria that causes bad breath. The best part is that its effects last for more than four hours.

This probably sounds like a claim you’ve heard before, but if you look closely at the ads for the plethora of breath-freshening products for sale, you won’t find any that claim to keep your breath fresh for one hour, much less four.

“They can’t make such claims, because the best they can give you is 20 minutes or so,” Lerman says. “That’s because they just mask the problem, instead of removing the bacteria that cause bad breath, keeping breath fresh and clean.”

The efficacy of the lollipop against halitosis was shown in a series of clinical trials on 75 individuals at the Hillel Yafe May Medical Center in Israel.

That’s the main difference between Breezy’s solution and major brands of mouthwashes that give you a boost of fresh breath but cannot prevent the quick return of halitosis, which is caused by bacteria. Once the mouthwash has dissipated, the bacteria reasserts itself, and bad breath soon follows.

Breezy’s Like candy overcomes that issue, according to Lerman, with slow-release microcapsules filled with safe, all-natural active agents that battle halitosis. The hard microcapsules assist in gently scraping the tongue to remove the food particles and bacteria that cause unpleasant odor. When the capsules open, they release the active ingredients, which continue to act against the germs for hours.

Tasty bacteria buster

“Our Like candy offers triple protection,” says Lerman. “The candy’s microcapsules scrub; the mint in the candy freshens; and the active agents combat bacteria. Like also acts as an on-the-go tongue scraper that facilitates scraping around and at the back of the tongue – a prime area for bacteria buildup – with significantly less gag reflex.”

Like is just an example of what Breezy can do; the lollipop is merely one iteration of an anti-halitosis platform the company is developing.

“We have several patents which cover the concept and the use of microcapsules for a scraping therapeutic effect,” Lerman says. Potential products will work against smoker’s breath, dry mouth (xerostomia), oral fungus (candida/thrush), and canker sores (mouth ulcer/aphtous stomatitis).

“The Like product is ready for the market, and we are finalizing funding for packaging and marketing,” Lerman says, adding that the company is in advanced talks with a European group for distribution and marketing of Breezy technology.

Along with Lerman, the Breezy team consists of co-founders Shimon Harpaz and Dr. Shlomo Barak. Harpaz has a business background, having worked with several other startups in the past, while Barak is a top Israeli dentist and maxillofacial surgeon.

The company was founded in 2007 with the backing of Lenny Sackstein, founder of Carmit Confectionery, one of Israel’s largest candy-makers. Breezy has its offices at the Trendlines Group’s Mofet B’Yehuda Venture Accelerator near Jerusalem. Trendlines is currently the main investor in the company.

“This is something the world has definitely been waiting for,” says Lerman. “With halitosis affecting approximately 50 percent of the adult population worldwide, consumers spend billions of dollars on products to make their breath smell clean and fresh. Finally, there is a product that consumers can really rely on to get rid of their bad breath. We expect a lot of people to like Like.”

In Israel, we LIVE the dream…every day
Alternative energy sources are on-line in Israel, not being dreamed about and planned in commitee…

65% of our drinking water will be coming from desalinized seawater within 3 years…

Practical electric cars go on sale in Israel this summer…

Israel plans expansion of solar power

Israel is planning an expansion of its solar-generated electricity with preparations to bring the first of more than 40 new solar plants onto the grid this summer.

Reprinted from jweekly.com

Arava Power is building the plants, including a $30 million, 20-acre Ketura Sun solar field in Israel’s scorching Negev desert, which will begin providing electricity to some 1,000 residents this summer.

Israel is pushing to become a world leader in alternative energy, with the government backing cutting-edge technologies and setting a goal to have 10 percent of its electricity generated by alternative means by 2020.

Right now, Israel depends almost entirely on imported coal and natural gas for its energy

The “brain drain” seems to be entering a “recycling” phase, as Israeli hi-tech brains continue to return home, amidst the influx of new, innovative talent flooding Israel…

General Electric to set up new Israeli R&D center

The Haifa R&D center will do basic research in medical devices, clean energy, and water technologies

Reprinted from globes.co.il

General Electric (NYSE: GE), one of the world’s largest companies, will open its a multidisciplinary R&D center in Israel, its eighth R&D center in the country, at an investment of $3-5 million. The R&D center will engage in research in medical devices, water, and clean energy.

The R&D center will be set up in Haifa, near the center of GE subsidiary GE Healthcare, which has hundreds of employees who work on medical imaging systems.

GE currently has 450 employees at seven centers in Israel, out of the company’s total global workforce of 30,000. GE has a market cap of $194 billion. The other Israeli centers focus on specific products, while the new R&D center in Haifa will conduct more basic and general research.

GE will hire 12 researchers when the new R&D center is opened. It will be headed by Oded Meirav, who has been VP business development at GE Global Research Center for the past four years. He was responsible for establishing GE’s collaborations with Israeli companies, such as medical devices companies InSightec Image Guided Treatment Ltd., WideMed Ltd. (TASE:WDMD), DeepBreeze Ltd., and Arineta Ltd.; with Shai Agassi’s electric car venture Better Place LLC; and with cleantech companies Desalitech Ltd., Emefcy Ltd., Solaredge Ltd., GridON Ltd., and Winflex Ltd.; and with water companies incubator Kinrot Technology Ventures.

One of GE’s goals in setting up the new center is to establish partnerships with Israeli high-tech companies and academe. “Israel has a rich history of innovation and scientific discovery, says GE Global Research VP advanced technologies Michael Idelchik. “With the establishment of the new R&D center, we will be in a better position to build a close relationship with the Israeli technology community and identify new technologies that could become part of our portfolio.”

The research team will focus on renewable energy, energy storage, smart grid, and energy efficiency technologies. It will also work on water monitoring, purification, wastewater treatment, brackish water and seawater desalination technology; and in healthcare, on non-invasive medical devices, advanced diagnostic tools, and medical navigation and guidance systems.

The R&D center’s researchers will collaborate with GE Capital’s life sciences and energy funds, which invest in innovative technologies.